(Total Views: 471)
Posted On: 10/19/2022 6:43:29 PM
Post# of 6857
Undisputable Facts Univec was on the Nasdaq before Dalton ever got involved, Doc became CEO 01/01//2002 the filing is at the bottom of this, he got CEO with the deal when he sold PPSI to UNVC in Dec. 2001
Rite Aid is on the NYSE
https://www.otcmarkets.com/filing/html?id=109...6fOuPcHJth
Item On July 2, 1999, the Registrant (UNVC)announced that it was delisted from the Nasdaq Small Cap Market in a press release, which is attached as Exhibit 99.1 and incorporated by reference herein (BW)(NY-UNIVEC)(UNVC) Univec Makes Announcement
Business & Medical/Health Editors
FARMINGDALE, N.Y. -- (BUSINESS WIRE) -- July 2, 1999 -- UNIVEC, Inc. (OTC:
"UNVC" announced that it was delisted from the Nasdaq SmallCap Market effective with the close of business June 30, 1999.
Although the Company believed it established its compliance with the continued listing requirements, a Nasdaq hearing panel was of the opinion that the Company failed to present a definitive plan which would enable it to sustain compliance over the long term. The Company intends to appeal the panel's decision to the Nasdaq Review Council. Trading in the Company's securities will now be conducted in the over-the-counter market in the so-called "pink sheets" or, on application by broker-dealers, in the NASD's Electronic Bulletin Board.
Joel Schoenfeld, UNIVEC's Chief Executive Officer, said, "This is obviously disappointing to us, coming at a time when we appear to be at a turning point with significant increases in orders and the Company having recently arranged for additional working capital."
UNIVEC develops, manufactures, licenses and markets safety auto-destruct hypodermic syringes, designed to protect healthcare workers against needle stick injuries and patients against cross-infection resulting from reused needles and syringes.
This press release contains Forward-Looking Statements. Statements in this news release looking forward in time are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that forward-looking statements involve risks and uncertainties. The Company's actual results could differ materially from those anticipated in the forward-looking statements as a result of certain factors.
CONTACT: UNIVEC, Inc., Farmingdale
Corporate Media & Investor Relations Officer David Gordon, 516/777-2000
Read More: https://investorshangout.com/post/view?id=645...z7iClotsAp
DR. DAVID DALTON became our President and Chief Executive Officer on January 1, 2002, concurrent with our acquisition of Physician and Pharmaceutical Services, Inc., a Baltimore based company founded by Dr. Dalton. Dr. Dalton has. over 35 years of experience with the healthcare industry, including 18 years with Rite-Aid where he served as Corporate Vice President. Dr. Dalton founded Health Resources, Inc. in 1983. Health Resources is a pharmacy service provider having contracts with over 50,000 retail pharmacies for billing and payment of prescription orders through plan providers. Dr. Dalton also founded Pharmacy Services, Inc., a pharmacy fulfillment center for correctional and other institutions, with facilities in Maryland, Tennessee and Pennsylvania.
Read More: https://investorshangout.com/post/view?id=645...z7iCmsrvYm
https://investorshangout.com/post/view?id=6458299
Rite Aid is on the NYSE
https://www.otcmarkets.com/filing/html?id=109...6fOuPcHJth
Item On July 2, 1999, the Registrant (UNVC)announced that it was delisted from the Nasdaq Small Cap Market in a press release, which is attached as Exhibit 99.1 and incorporated by reference herein (BW)(NY-UNIVEC)(UNVC) Univec Makes Announcement
Business & Medical/Health Editors
FARMINGDALE, N.Y. -- (BUSINESS WIRE) -- July 2, 1999 -- UNIVEC, Inc. (OTC:
"UNVC" announced that it was delisted from the Nasdaq SmallCap Market effective with the close of business June 30, 1999.
Although the Company believed it established its compliance with the continued listing requirements, a Nasdaq hearing panel was of the opinion that the Company failed to present a definitive plan which would enable it to sustain compliance over the long term. The Company intends to appeal the panel's decision to the Nasdaq Review Council. Trading in the Company's securities will now be conducted in the over-the-counter market in the so-called "pink sheets" or, on application by broker-dealers, in the NASD's Electronic Bulletin Board.
Joel Schoenfeld, UNIVEC's Chief Executive Officer, said, "This is obviously disappointing to us, coming at a time when we appear to be at a turning point with significant increases in orders and the Company having recently arranged for additional working capital."
UNIVEC develops, manufactures, licenses and markets safety auto-destruct hypodermic syringes, designed to protect healthcare workers against needle stick injuries and patients against cross-infection resulting from reused needles and syringes.
This press release contains Forward-Looking Statements. Statements in this news release looking forward in time are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that forward-looking statements involve risks and uncertainties. The Company's actual results could differ materially from those anticipated in the forward-looking statements as a result of certain factors.
CONTACT: UNIVEC, Inc., Farmingdale
Corporate Media & Investor Relations Officer David Gordon, 516/777-2000
Read More: https://investorshangout.com/post/view?id=645...z7iClotsAp
DR. DAVID DALTON became our President and Chief Executive Officer on January 1, 2002, concurrent with our acquisition of Physician and Pharmaceutical Services, Inc., a Baltimore based company founded by Dr. Dalton. Dr. Dalton has. over 35 years of experience with the healthcare industry, including 18 years with Rite-Aid where he served as Corporate Vice President. Dr. Dalton founded Health Resources, Inc. in 1983. Health Resources is a pharmacy service provider having contracts with over 50,000 retail pharmacies for billing and payment of prescription orders through plan providers. Dr. Dalton also founded Pharmacy Services, Inc., a pharmacy fulfillment center for correctional and other institutions, with facilities in Maryland, Tennessee and Pennsylvania.
Read More: https://investorshangout.com/post/view?id=645...z7iCmsrvYm
https://investorshangout.com/post/view?id=6458299
(4)
(0)
